BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12577567)

  • 1. [Oncologic markers in the diagnosis of malignant tumors of the digestive tract].
    Maĭstrenko NA; Kurygin AA; Khrykov GN
    Vestn Khir Im I I Grek; 2002; 161(4):102-6. PubMed ID: 12577567
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in cancer of the digestive system].
    Zinser JW
    Rev Gastroenterol Mex; 1997; 62(3):145-8. PubMed ID: 9480520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
    Hori H; Ajiki T; Fujita T; Okazaki T; Suzuki Y; Kuroda Y; Fujimori T
    Jpn J Clin Oncol; 2006 Oct; 36(10):638-42. PubMed ID: 16908513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of tumor markers (among which carcinoembryonal antigen) in the diagnosis of malignant tumors in the gastrointestinal tract].
    Wobbes T; Thomas CM; Segers MF
    Ned Tijdschr Geneeskd; 1993 May; 137(20):995-9. PubMed ID: 7685066
    [No Abstract]   [Full Text] [Related]  

  • 5. [P53 tumor suppressor gene in digestive neoplasms].
    Roa JC; Roa I; Araya JC; Villaseca MA; Melo A; Burgos L
    Rev Med Chil; 2000 Nov; 128(11):1269-78. PubMed ID: 11347516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "OMICS" technologies and their role in foregut primary malignancies.
    Farid SG; Morris-Stiff G
    Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C; Bei L; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ca-19-9, carcinoembryonic antigen, and alpha-fetoprotein in the serum of nononcological patients and their clinical significance].
    Skvortsov SV; Kushlinskiĭ NE; Kadagidze ZG; Kasumov ChM
    Biull Eksp Biol Med; 1997 May; 123(5):566-9. PubMed ID: 9264714
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunohistochemical analysis for cholangiocarcinoma].
    Nakagoe T; Matsuo T; Kondoh M; Yamaguchi H
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():370-4. PubMed ID: 16457285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
    Marecek Z
    Vnitr Lek; 1997 Mar; 43(3):167-70. PubMed ID: 9221578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers for neoplasmas in digestive organs].
    Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathological and diagnostic value of genetic changes in digestive cancers].
    Laurent-Puig P; Fléjou JF
    Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B21-26. PubMed ID: 8761118
    [No Abstract]   [Full Text] [Related]  

  • 13. [What can be done for patients with cancer of the digestive tract in 2003? Guidelines of the Francophone Federation of Digestive Tract Cancerology--part II].
    Conseil Scientifique de La FFCD
    Gastroenterol Clin Biol; 2003 Jan; 27(1):43-58. PubMed ID: 12594364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor markers in primary and metastatic liver cancer and cancer of the pancreas].
    Moroz GS; Andreĭchin MA; Kudin AT; Kiĭko LG
    Sov Med; 1988; (12):116-7. PubMed ID: 2468187
    [No Abstract]   [Full Text] [Related]  

  • 15. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoembryonic antigen (CEA)].
    Kinugasa T; Kuroki M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of early immunocytochemical diagnosis in periampullary tumors (a review of foreign literature)].
    Kubyshkin VA; Dauda M
    Khirurgiia (Mosk); 1995; (6):50-2. PubMed ID: 8569126
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum oncofetal antigens in the diagnosis of malignancies in gastroenterohepatology].
    Libman E; Stojsić S; Lemberger J; Novak A
    Med Pregl; 1988; 41(11-12):467-72. PubMed ID: 2473385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.